4/17
09:57 pm
dftx
Is It Too Late To Consider Definium Therapeutics (DFTX) After Its Strong 1 Year Run? [Yahoo! Finance]
Neutral
Report
Is It Too Late To Consider Definium Therapeutics (DFTX) After Its Strong 1 Year Run? [Yahoo! Finance]
4/17
02:01 pm
dftx
Definium: 'Strong Buy' Maintained On Several Anticipated 2026 Milestones [Seeking Alpha]
Low
Report
Definium: 'Strong Buy' Maintained On Several Anticipated 2026 Milestones [Seeking Alpha]
4/17
03:37 am
dftx
Definium Therapeutics Teases 3 Phase III DT120 Readouts in 2026, Starting Late Q2 MDD Data [Yahoo! Finance]
Low
Report
Definium Therapeutics Teases 3 Phase III DT120 Readouts in 2026, Starting Late Q2 MDD Data [Yahoo! Finance]
4/16
07:03 pm
dftx
Definium Therapeutics (DFTX) was given a new $30.00 price target by Stifel Nicolaus.
Low
Report
Definium Therapeutics (DFTX) was given a new $30.00 price target by Stifel Nicolaus.
4/16
08:07 am
dftx
Definium Therapeutics (DFTX) was given a new $38.00 price target by Canaccord Genuity Group Inc..
Low
Report
Definium Therapeutics (DFTX) was given a new $38.00 price target by Canaccord Genuity Group Inc..
4/10
08:43 am
dftx
Definium Therapeutics (DFTX) is now covered by Piper Sandler. They set an "overweight" rating and a $49.00 price target on the stock.
Low
Report
Definium Therapeutics (DFTX) is now covered by Piper Sandler. They set an "overweight" rating and a $49.00 price target on the stock.
4/9
07:00 am
dftx
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Low
Report
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
4/3
08:40 pm
dftx
Can Definium Therapeutics (DFTX) Turn GAD Prevalence And DT120 Breakthrough Status Into Durable Advantage? [Yahoo! Finance]
Low
Report
Can Definium Therapeutics (DFTX) Turn GAD Prevalence And DT120 Breakthrough Status Into Durable Advantage? [Yahoo! Finance]
2/26/2026
04:01 pm
dftx
definium therapeutics, inc. - common shares
MISS
Report
0.9%
definium therapeutics, inc. - common shares
3/26
06:43 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Karlin Daniel
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Karlin Daniel
3/26
06:43 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Sullivan Mark
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Sullivan Mark
3/26
06:42 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Barrow Robert
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Barrow Robert
3/25
05:41 pm
dftx
Form 144 Definium Therapeutics, Filed by: Barrow Robert
Low
Report
Form 144 Definium Therapeutics, Filed by: Barrow Robert
3/25
05:40 pm
dftx
Form 144 Definium Therapeutics, Filed by: Karlin Daniel
Low
Report
Form 144 Definium Therapeutics, Filed by: Karlin Daniel
3/25
05:40 pm
dftx
Form 144 Definium Therapeutics, Filed by: Sullivan Mark
Low
Report
Form 144 Definium Therapeutics, Filed by: Sullivan Mark
2/26
04:25 pm
dftx
Form 10-K Definium Therapeutics, For: Dec 31
Low
Report
Form 10-K Definium Therapeutics, For: Dec 31
2/26
04:15 pm
dftx
Form 8-K Definium Therapeutics, For: Feb 26
Low
Report
Form 8-K Definium Therapeutics, For: Feb 26
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register